Literature DB >> 24657617

Diverse diseases from a ubiquitous process: the ribosomopathy paradox.

Joy Armistead1, Barbara Triggs-Raine2.   

Abstract

Collectively, the ribosomopathies are caused by defects in ribosome biogenesis. Although these disorders encompass deficiencies in a ubiquitous and fundamental process, the clinical manifestations are extremely variable and typically display tissue specificity. Research into this paradox has offered fascinating new insights into the role of the ribosome in the regulation of mRNA translation, cell cycle control, and signaling pathways involving TP53, MYC and mTOR. Several common features of ribosomopathies such as small stature, cancer predisposition, and hematological defects, point to how these diverse diseases may be related at a molecular level.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  IRES elements; Ribosome biogenesis; Ribosomopathy; Tissue specificity

Mesh:

Substances:

Year:  2014        PMID: 24657617     DOI: 10.1016/j.febslet.2014.03.024

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  57 in total

1.  Chemical modulators of ribosome biogenesis as biological probes.

Authors:  Jonathan M Stokes; Eric D Brown
Journal:  Nat Chem Biol       Date:  2015-11-17       Impact factor: 15.040

Review 2.  Pathways to Specialized Ribosomes: The Brussels Lecture.

Authors:  Jonathan D Dinman
Journal:  J Mol Biol       Date:  2016-01-04       Impact factor: 5.469

Review 3.  Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Authors:  Yu-Hsuan Lin; Brittany E Jewell; Julian Gingold; Linchao Lu; Ruiying Zhao; Lisa L Wang; Dung-Fang Lee
Journal:  Trends Mol Med       Date:  2017-07-20       Impact factor: 11.951

4.  EIF4A3 deficient human iPSCs and mouse models demonstrate neural crest defects that underlie Richieri-Costa-Pereira syndrome.

Authors:  Emily E Miller; Gerson S Kobayashi; Camila M Musso; Miranda Allen; Felipe A A Ishiy; Luiz Carlos de Caires; Ernesto Goulart; Karina Griesi-Oliveira; Roseli M Zechi-Ceide; Antonio Richieri-Costa; Debora R Bertola; Maria Rita Passos-Bueno; Debra L Silver
Journal:  Hum Mol Genet       Date:  2017-06-15       Impact factor: 6.150

5.  CBFβ-SMMHC regulates ribosomal gene transcription and alters ribosome biogenesis.

Authors:  G Cordonnier; A Mandoli; A Radhouane; G Hypolite; L Lhermitte; M Belhocine; V Asnafi; E Macintyre; J H A Martens; S Fumagalli; J Bond
Journal:  Leukemia       Date:  2017-02-15       Impact factor: 11.528

6.  Ribosome biogenesis dysfunction leads to p53-mediated apoptosis and goblet cell differentiation of mouse intestinal stem/progenitor cells.

Authors:  A Stedman; S Beck-Cormier; M Le Bouteiller; A Raveux; S Vandormael-Pournin; S Coqueran; V Lejour; L Jarzebowski; F Toledo; S Robine; M Cohen-Tannoudji
Journal:  Cell Death Differ       Date:  2015-06-12       Impact factor: 15.828

Review 7.  Translation regulation by ribosomes: Increased complexity and expanded scope.

Authors:  Vincent P Mauro; Daiki Matsuda
Journal:  RNA Biol       Date:  2015-10-29       Impact factor: 4.652

Review 8.  Principles of 60S ribosomal subunit assembly emerging from recent studies in yeast.

Authors:  Salini Konikkat; John L Woolford
Journal:  Biochem J       Date:  2017-01-15       Impact factor: 3.857

9.  Ribosome biogenesis factor Tsr3 is the aminocarboxypropyl transferase responsible for 18S rRNA hypermodification in yeast and humans.

Authors:  Britta Meyer; Jan Philip Wurm; Sunny Sharma; Carina Immer; Denys Pogoryelov; Peter Kötter; Denis L J Lafontaine; Jens Wöhnert; Karl-Dieter Entian
Journal:  Nucleic Acids Res       Date:  2016-04-15       Impact factor: 16.971

10.  A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition.

Authors:  Chang-Hyun Lee; Marianthi Kiparaki; Jorge Blanco; Virginia Folgado; Zhejun Ji; Amit Kumar; Gerard Rimesso; Nicholas E Baker
Journal:  Dev Cell       Date:  2018-08-02       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.